Eribulin monotherapy improved survivals in patients with ER-positive HER2-negative metastatic breast cancer in the real world: a single institutional review
Crossref DOI link: https://doi.org/10.1186/s40064-015-1422-8
Published Online: 2015-10-19
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Watanabe, Junichiro
Funding for this research was provided by:
Eisai Co., Ltd.
License valid from 2015-10-19